Empagliflozin: Role in Treatment Options for Patients with Type 2 Diabetes Mellitus
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1869-6961
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Empagliflozin: Role in Treatment Options for Patients with Type 2 Diabetes Mellitus ; day:11 ; month:11 ; year:2016 ; pages:1-21
Diabetes therapy ; (11.11.2016), 1-21
- Urheber
-
Anderson, John E.
- Beteiligte Personen und Organisationen
-
Wright, Eugene E.
Shaefer, Charles F.
SpringerLink (Online service)
- DOI
-
10.1007/s13300-016-0211-x
- URN
-
urn:nbn:de:1111-201612049020
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Anderson, John E.
- Wright, Eugene E.
- Shaefer, Charles F.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Pooled Safety and Tolerability Analysis of Empagliflozin in Patients with Type 2 Diabetes Mellitus
Empagliflozin (Diabetes mellitus Typ 2) : Addendum zum Auftrag A16-12
Empagliflozin/Metformin (Diabetes mellitus Typ 2) : Addendum zum Auftrag A16-13
Empagliflozin/Linagliptin (Diabetes mellitus Typ 2) : Nutzenbewertung gemäß § 35a SGB V
Empagliflozin on top of metformin treatment improves arterial function in patients with type 1 diabetes mellitus
Fournier’s Gangrene in a Patient with Type 2 Diabetes Mellitus Treated with Empagliflozin: A Case Report
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of Empagliflozin in Patients with Type 2 Diabetes Mellitus
How does empagliflozin improve arterial stiffness in patients with type 2 diabetes mellitus? Sub analysis of a clinical trial
How does empagliflozin improve arterial stiffness in patients with type 2 diabetes mellitus? Sub analysis of a clinical trial
Empagliflozin’s role in early tubular protection for type 2 diabetes patients
Effect of Empagliflozin Versus Placebo on Cardiac Sympathetic Activity in Acute Myocardial Infarction Patients with Type 2 Diabetes Mellitus: Rationale
Empagliflozin influences blood viscosity and wall shear stress in subjects with type 2 diabetes mellitus compared with incretin-based therapy
Pooled Safety and Tolerability Analysis of Empagliflozin in Patients with Type 2 Diabetes Mellitus
Empagliflozin (Diabetes mellitus Typ 2) : Addendum zum Auftrag A16-12
Empagliflozin/Metformin (Diabetes mellitus Typ 2) : Addendum zum Auftrag A16-13
Empagliflozin/Linagliptin (Diabetes mellitus Typ 2) : Nutzenbewertung gemäß § 35a SGB V
Empagliflozin on top of metformin treatment improves arterial function in patients with type 1 diabetes mellitus
Fournier’s Gangrene in a Patient with Type 2 Diabetes Mellitus Treated with Empagliflozin: A Case Report
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of Empagliflozin in Patients with Type 2 Diabetes Mellitus
How does empagliflozin improve arterial stiffness in patients with type 2 diabetes mellitus? Sub analysis of a clinical trial
How does empagliflozin improve arterial stiffness in patients with type 2 diabetes mellitus? Sub analysis of a clinical trial
Empagliflozin’s role in early tubular protection for type 2 diabetes patients
Effect of Empagliflozin Versus Placebo on Cardiac Sympathetic Activity in Acute Myocardial Infarction Patients with Type 2 Diabetes Mellitus: Rationale
Empagliflozin influences blood viscosity and wall shear stress in subjects with type 2 diabetes mellitus compared with incretin-based therapy
Pooled Safety and Tolerability Analysis of Empagliflozin in Patients with Type 2 Diabetes Mellitus
Empagliflozin (Diabetes mellitus Typ 2) : Addendum zum Auftrag A16-12
Empagliflozin/Metformin (Diabetes mellitus Typ 2) : Addendum zum Auftrag A16-13
Empagliflozin/Linagliptin (Diabetes mellitus Typ 2) : Nutzenbewertung gemäß § 35a SGB V
Empagliflozin on top of metformin treatment improves arterial function in patients with type 1 diabetes mellitus
Fournier’s Gangrene in a Patient with Type 2 Diabetes Mellitus Treated with Empagliflozin: A Case Report
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of Empagliflozin in Patients with Type 2 Diabetes Mellitus
How does empagliflozin improve arterial stiffness in patients with type 2 diabetes mellitus? Sub analysis of a clinical trial
How does empagliflozin improve arterial stiffness in patients with type 2 diabetes mellitus? Sub analysis of a clinical trial
Empagliflozin’s role in early tubular protection for type 2 diabetes patients
Effect of Empagliflozin Versus Placebo on Cardiac Sympathetic Activity in Acute Myocardial Infarction Patients with Type 2 Diabetes Mellitus: Rationale